Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Leukemia & Lymphoma|August 25, 2020
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphomaKishan K Patel, Iris Isufi, Shalin Kothari, et al.JAMA Network Open|January 12, 2021
Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal CancerKishan K Patel, Stacey Stein, Jill Lacy, et al.Leukemia & Lymphoma|June 21, 2021
Cost-effectiveness of once-weekly selinexor, bortezomib, and dexamethasone in relapsed or refractory multiple myelomaKishan K Patel, Terri Parker, Mengyang Di, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple MyelomaKishan K Patel, Smith Giri, Terri L Parker, et al.Archives of Pathology & Laboratory Medicine|December 8, 2020
Clinicopathologic Features of Tissue Granulomas in Transplant Recipients: A Single Center Study in a Nontuberculosis Endemic RegionEliezer Zachary Nussbaum, Kishan K Patel, Roland Assi, et al.Blood Advances|February 16, 2021
Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemiaKishan K Patel, Amer M Zeidan, Rory M Shallis, et al.Blood|June 11, 2020
Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemiaKishan K Patel, Iris Isufi, Shalin Kothari, et al.Neurochemistry International|July 9, 2014
Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 miceNatalie M Frederick, Julie Bertho, Kishan K Patel, et al.Academic Pediatrics|May 16, 2022
Association of Food Insecurity with Mental Health Outcomes in Parents and ChildrenKathryn S Cain, Stephanie C Meyer, Elaina Cummer, et al.Pageof 2